Physiological Vibration Acceleration (Phybrata) Sensor Assessment of Multi-System Physiological Impairments and Sensory Reweighting Following Concussion.
John D Ralston, Ashutosh Raina, Brian W Benson...
https://pubmed.ncbi.nlm.nih.gov/33324120Actively Recruiting
Led by Neursantys Inc · Updated on 2025-02-25
500
Participants Needed
4
Research Sites
N/A
Total Duration
N
Neursantys Inc
Lead Sponsor
M
Mitacs
Collaborating Sponsor
This research aims to evaluate the safety, feasibility, effectiveness, and lasting impact of non-invasive electrical vestibular stimulation (EVS) on balance and walking ability in healthy adults aged 18 to 100 years. It focuses on how EVS influences balance and gait by measuring performance before, during, and after single and repeated sessions at multiple partner sites. The study addresses age-related balance decline, known as presbystasis, which increases fall risk and affects independence, especially in older adults, and explores EVS as a potential non-invasive solution to restore vestibular function and possibly improve cognitive function and headaches. Participants will receive either active treatment with sub-threshold wideband stochastic EVS (swsEVS) or a sham treatment with no stimulation, in a randomized, single-blind design. The study involves 18 testing sessions over 5 to 6 weeks, where participants undergo EVS while alternating sitting and standing positions with eyes open or closed. Several assessments will be conducted including accelerometer-based gait and balance tests using a smartphone app, clinician-administered Functional Gait Assessments, static and dynamic balance tests, cognitive tests, and questionnaires about headaches and dizziness. Participants will complete balance and gait tests before and after each EVS session, with follow-up visits at 3 weeks, 6 weeks, 3 months, and 6 months post-treatment to evaluate lasting effects. Cognitive assessments and headache questionnaires are done during the first and last treatment sessions. Safety and tolerability are monitored throughout. The main outcomes measured include various balance and gait parameters such as postural sway, gait velocity, cadence, step length, and step trajectory, along with cognitive performance tests, to assess the impact of the stimulation over time.
CONDITIONS
Therapeutic Effects of Electrical Vestibular Stimulation (EVS) on Balance and Gait
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 5 to 6 weeks
Participants receive 18 sessions of electrical vestibular stimulation (swsEVS) or sham stimulation over a 5-6 week period to improve balance and gait performance. Each session includes gait and balance tests before and after a single 20-minute stimulation session.
18 visits (in-person) with gait and balance testing before and after each session
Duration - 6 months
Participants return for follow-up visits at 3 weeks, 6 weeks, 3 months, and 6 months after treatment to repeat gait and balance tests and assess the persistence of any improvements.
4 visits (in-person) at 3 weeks, 6 weeks, 3 months, and 6 months post-treatment
Total: 4 locations
1
Caring Hands Caregivers
Cupertino, California, United States, 95014
Actively Recruiting
2
Neursantys
Menlo Park, California, United States, 94025
Actively Recruiting
3
University of Calgary
Calgary, Alberta, Canada, T2N 1N4
Actively Recruiting
4
Sparx Wellness Institute
Dieppe, New Brunswick, Canada, E1A 1P2
Actively Recruiting
R
Ryan M Peters, PhD
J
John D Ralston, PhD
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
John D Ralston, Ashutosh Raina, Brian W Benson...
https://pubmed.ncbi.nlm.nih.gov/33324120Valentina Dilda, Hamish G MacDougall, Ian S Curthoys...
https://pubmed.ncbi.nlm.nih.gov/22076407Christophe Lopez, Kathleen E Cullen
https://pubmed.ncbi.nlm.nih.gov/37889571Anna Paula Batista de Ávila Pires, Tatiana Rocha Silva, Maíra Soares Torres...
https://pubmed.ncbi.nlm.nih.gov/35915031Julia Dlugaiczyk, Kathrin D Gensberger, Hans Straka
https://pubmed.ncbi.nlm.nih.gov/30995162A Deveze, L Bernard-Demanze, F Xavier...
https://pubmed.ncbi.nlm.nih.gov/24502905Paul F Smith
https://pubmed.ncbi.nlm.nih.gov/38038627Shinichi Iwasaki, Tatsuya Yamasoba
https://pubmed.ncbi.nlm.nih.gov/25657851L E Davis
https://pubmed.ncbi.nlm.nih.gov/7963205Jordan A King, Noah Walters, Nadine Rodrigues...
https://pubmed.ncbi.nlm.nih.gov/41174737